The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of ALTER-C002: Anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer.
 
Ke-Feng Ding
No Relationships to Disclose
 
Yue Liu
No Relationships to Disclose
 
Qian Xiao
No Relationships to Disclose
 
Jinjie He
No Relationships to Disclose
 
Hanguang Hu
No Relationships to Disclose
 
Jinlin Du
No Relationships to Disclose
 
Yuping Zhu
No Relationships to Disclose
 
Jiaqi Chen
No Relationships to Disclose
 
Zhuo Liu
No Relationships to Disclose
 
Jianping Wang
No Relationships to Disclose
 
Lifeng Sun
No Relationships to Disclose
 
Dong Xu
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Xiujun Liao
No Relationships to Disclose
 
Jianwei Wang
No Relationships to Disclose
 
Yibo Cai
No Relationships to Disclose
 
Cheng Cai
No Relationships to Disclose
 
Zhekang Jin
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose